Skip to content
-
August 31, 2021
VIDEO: Michael Zody, PhD, Discusses Collaborative SARS-CoV-2 Viral Surveillance Initiatives at the NYGC
-
August 30, 2021
Sanjana Lab of NYGC/NYU Extends RNA-Targeting CRISPR-Cas13 Genomics Tools to Model Organisms and Viruses Including SARS-CoV-2
-
August 2, 2021
Sanjana Lab of NYGC/NYU Boosts Gene Knockdown in Human Cells With CRISPR-Cas13 Using Chemically-Modified Guide RNAs
-
August 2, 2021
Tom Maniatis, PhD, NYGC Evnin Family Scientific Director & CEO, Named to City & State’s First “Life Sciences Power 50” List
-
July 26, 2021
Study Links New Set of Rare Gene Variants to Autism
-
June 24, 2021
C2i Genomics, NYGC/WCM Liquid Biopsy Spinout Company, Shortlisted for Nature’s Spinoff Prize
-
June 11, 2021
Dr. Neville Sanjana Interviewed in “What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health” Feature Article
-
June 8, 2021
A “Scoping Review” Out of Africa Highlights Need for More Studies of Neuropsychiatric Disease in Diverse Populations
-
May 10, 2021
New Mapping Technique Reveals Epigenetic Drivers of Cancers
-
April 29, 2021
Single-Cell CRISPR Technology Deciphers Role of Chromatin Accessibility in Cancer